• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,583.69 98.81
(0.18%)
Dow Jones
7,750.97 54.27
(0.71%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.26 -0.05
(-0.05%)
EUR-INR
111.07 -0.11
(-0.10%)
GBP-INR
129.70 -0.28
(-0.21%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
43.92
44244.24
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.79
 

Nihar Info Global reports consolidated net profit of Rs 0.03 crore in the March 2026 quarter
Jun 01,2026
Net profit of Nihar Info Global reported to Rs 0.03 crore in the quarter ended March 2026 as against net loss of Rs 3.41 crore during the previous quarter ended March 2025. Sales declined 10.55% to Rs 3.73 crore in the quarter ended March 2026 as against Rs 4.17 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.69 crore in the year ended March 2026 as against net loss of Rs 3.60 crore during the previous year ended March 2025. Sales rose 180.70% to Rs 21.67 crore in the year ended March 2026 as against Rs 7.72 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.734.17 -11 21.677.72 181
OPM %1.88-80.10 -4.06-43.39 -
PBDT0.03-3.38 LP 0.74-3.51 LP
PBT0.03-3.38 LP 0.74-3.53 LP
NP0.03-3.41 LP 0.69-3.60 LP